Adherium

It follows the clearance for connecting Hailie with AstraZeneca's Symbicort inhaler.

Also: Digital therapeutics company Palo Alto Health Sciences reports $9.1 million; Adherium gains new support from investment firm Viburnum.

Also: quip to sell its oral health products at Target; HealthEdge's software suite coming to Fluent Health.

Bankrupting docs? Patient booking platform Zocdoc is putting providers in a sticky situation, CNBC reports.

Connected inhaler sensor maker Adherium has received 510(k) clearance for US over-the-counter sales of its Hailie sensor, formerly known as Smartinhaler.

Interest in digital health is now sprouting up all over DC, from the president’s announcement of a new AI task force to FDA Commissioner’s shout out to digital health in his budget request.

Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called the SmartTouch for Symbicort.

Yesterday, Dr.

New Zealand-based smart inhaler company Adherium, which up until now has distributed its products via pharma sales channels in Europe and Australia, plans to expand into the United States in the first half of 2018 with a direct-to-consumer (and direct-to-payer) strategy.

Omada Health has announced five new senior hires, most notably a new chief medical officer, Dr.